相关实验视频
Updated: Jul 26, 2025

08:18
Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
3.4K
纳灵宁改善了涉及SIRT1激活的血管衰老和动脉样硬化
Jie Wang1, Ruoman Wu1, Yiqiao Hua1
1Department of Pharmacology, Nantong University Pharmacy College, Nantong, China.
The Journal of pharmacy and pharmacology
|June 21, 2023
概括
纳灵宁通过激活SIRT1.1,有效地治疗小鼠的血管衰老和动脉样硬化. 这种激活导致FOXO3a和PGC1α的脱和调节,改善细胞健康.
科学领域:
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
- 衰老研究研究 衰老研究
背景情况:
- 动脉样硬化症的特征是血管衰老和氧化应激.
- SIRT1信号通路在细胞平衡和衰老中起着至关重要的作用.
研究的目的:
- 为了研究纳灵宁对动脉样硬化的血管衰老的影响.
- 阐明涉及SIRT1介导信号通路的机制.
主要方法:
- 年长的apoE-/-小鼠被用naringenin治疗了三个月.
- 分析了脂质参数,大动脉病理和蛋白质表达.
- 在实验室中,使用H2O2.2,诱导内皮细胞衰老.
主要成果:
- 在小鼠中,纳灵宁治疗改善了脂质不良,动脉样硬化病变和血管衰老.
- 纳林根因降低了氧化应激和线粒体反应性氧物种 (ROS) 生产.
- 纳林根因增强了SIRT1活动和其点FOXO3a和PGC1α的脱乙烯化,SIRT1siRNA减弱了效应.
结论:
- 纳灵宁证明了对血管衰老和动脉样硬化的治疗潜力.
- 激活SIRT1,导致FOXO3a和PGC1α的调节,是naringenin的好处的一个关键机制.
相关概念视频
Nitric Oxide Signaling Pathway
5.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K
Antihypertensive Drugs: Vasodilators
580
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
580
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
469
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
469
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Mitochondria
14.0K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.0K

